Revolution Medicines saw the highest growth of 1.66% in patent filings in May and 1.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.49% and grants by 1.99%. GlobalData’s DataBook provides a comprehensive analysis of Revolution Medicines‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Revolution Medicines has been focused on protecting inventions in United States(US) with seven publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 25% filings and 50% grants. The United States(US), World Intellectual Property Organization(WIPO), Israel(IL), and Australia(AU) patent Office are among the top ten patent offices where Revolution Medicines is filings its patents. Among the top granted patent authorities, Revolution Medicines has 50% of its grants in United States(US) and 50% in Israel(IL).
Roche could be the strongest competitor for Revolution Medicines
Patents related to rare diseases lead Revolution Medicines's portfolio
Revolution Medicines has the highest number of patents in rare diseases. For rare diseases, nearly 100% of patents were filed and no patents were granted in Q2 2024.
Leukemia related patents lead Revolution Medicines portfolio followed by noonan syndrome, and neuroblastoma
Revolution Medicines has highest number of patents in leukemia followed by noonan syndrome, neuroblastoma, melanoma.
For comprehensive analysis of Revolution Medicines's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
